The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMediumUpdated×4•Originally published 7 May 2026•Updated 8 May 2026•

1 min read

Mixed Earnings Results as Tech and Growth Sectors Continue to Outperform

Key Facts

1Celsius Holdings reported earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.29.

2Canadian Natural Resources reported earnings of $0.85 per share, surpassing the estimate of $0.74.

26 days ago

Version History

3 additional sources confirmed this story

Version 426 days ago

What changed: Added specific EPS beat figures for CELH, the 148% net income growth percentage, and the new price target from Morgan Stanley.

Version 326 days ago

What changed: The story was updated to include disappointing earnings results from Cresco Labs, which contrasted with the previous trend of positive beats.

Version 227 days ago

What changed: Updated the story with specific financial metrics for Celsius Holdings, including record revenue of $783M and its 20.9% market share milestone.

Version 127 days ago

What changed: The story was updated to include a new batch of earnings reports from Affirm, Astrana Health, HubSpot, Innodata, and Microchip Technology, all of which exceeded analyst estimates.

Financial markets witnessed a series of robust earnings reports, highlighted by Celsius Holdings' exceptional performance as net income surged 148% to $110.10 million. The company reported earnings per share of $0.41, significantly beating the $0.29 expected, prompting Morgan Stanley to set a new price target of $55 despite the stock trading near its 52-week low of $31.80. In the technology sector, HubSpot reported earnings of $2.72 per share, while Microchip Technology posted $0.57 per share, surpassing consensus. Astrana Health and Affirm Holdings also exceeded analyst estimates. However, this positive trend was tempered by Cresco Labs Inc., which reported a quarterly loss of $0.04 per share, missing the Zacks Consensus Estimate of a $0.03 loss.